Status:
RECRUITING
TabCAT Brain Health Assessment in Primary Care
Lead Sponsor:
University of California, San Francisco
Collaborating Sponsors:
Kaiser Permanente
National Institute of Neurological Disorders and Stroke (NINDS)
Conditions:
Mild Cognitive Impairment
Dementia
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Efficient and user-friendly paradigms to detect cognitive impairment, including dementia are needed in primary care. The TabCAT Brain Health Assessment accurately detects cognitive impairment via an a...
Detailed Description
Twenty-six Kaiser Permanente Southern California (KPSC) primary care clinics will be randomized in two waves to receive either the TabCAT-BHA paradigm or usual care. Clinics have been matched in pairs...
Eligibility Criteria
Inclusion
- Patient with at least one encounter at an intervention clinic during the intervention period
- Age 18+ (limited to 65+ for primary analyses)
Exclusion
- Patients under the age of 18.
Key Trial Info
Start Date :
July 27 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2026
Estimated Enrollment :
180000 Patients enrolled
Trial Details
Trial ID
NCT06090578
Start Date
July 27 2023
End Date
December 31 2026
Last Update
October 31 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kaiser Permanente Southern California Department of Research & Evaluation
Pasadena, California, United States, 91101